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INTRODUCTION 
 
The first evidences indicating that angiotensin II (ANG II) was a peptide with action 
on the brain were shown in 1961 when it was found that the intraventricular injection of 
ANG II induces a centrally mediated pressor response (1). As a neuropeptide, ANG II 
belongs to the class of neuromodulators. The brain renin angiotensin system (RAS) exerts 
paracrine, autocrine and intracrine functions independently of circulating blood-borne ANG 
II which has a limited access to the brain by the blood-brain barrier (BBB) in the 
circumventricular organs (CVOs) (2). Brain-generated ANG II controls several 
physiological processes like stimulation of thirst, water intake and sodium appetite, acting 
as a neurotransmitter in neurons of brain areas such as the Subfornical organ (SFO) and 
Organum vasculosum of the lamina terminalis (OVLT). Generated angiotensins (ANGs) at 
the central nervous system (CNS) also stimulate endocrine secretions like arginine-
vasopressin (AVP), oxytocin (OT), corticotrophin-releasing hormone (CRH) and 
adenocorticotrophin (ACTH secretion). Brain ANG II modulates the sympathetic 
autonomic functions and regulates blood pressure by increasing AVP and ACTH secretion 
and modulating the baroceptor reflex and the sympathetic output (3). During the last decade 
it has been established that, apart from its classical actions, ANG II exhibits other effects 
induced by direct action on its receptors or via local effects of its metabolites (4). Thereby, 
central actions of ANGs are not exclusively associated with their traditional roles. Indeed, 
several studies have shown that central ANGs are also involved in sexual behavior, stress, 
learning, and memory (5).  
 The endogenous brain RAS modulates the hypothalamic-pituitary-adrenal axis 
through the synthesis and secretion control of hypothalamic releasing factors. It also 
regulates cardiovascular function and hydromineral balance through modulation of water 
and sodium intake and controlling thirst, salt appetite and water excretion, overlapping 
many of ANG II peripheral effects. Brain RAS stimulates central autonomic nervous 
sympathetic activity, controlling central and peripheral sympathoadrenal systems and 
regulating neuronal norepinephrine (NE) neurotransmission and, as a as a derived action of 
this, brain and body temperature. Brain ANG II also controls the diurnal rhythms, 
modulating serotonin transmission by stimulation of neuronal serotonin synthesis and 
release. The central RAS may be involved in the regulation of multiple additional functions 
in the brain, which are not completely established, including brain development, neuronal 
migration, processes of sensory information, cognition, learning, retention and memory, 
regulation of emotional responses, sexual behaviour, apoptosis as well as the cerebral blood 
flow (6).      
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On the other hand, new peptides have been identified as metabolic products of ANG 
II, like the heptapeptide ANG III (fragment 2-8), the hexapeptide ANG IV (fragment 3-8) 
and the heptapeptide ANG 1-7 (fragment 1-7). These members of the ANG family are 
biologically active peptides formed in the CNS and play different roles in the brain as 
neurotransmitters, exciting neurons with high specificity and also as neuroendocrine, 
paracrine, autocrine and intracrine factors. Finally, other members like ANG fragments 3-7, 
1-9 and 2-10 are relatively poorly known and further research will be needed in order to 
elucidate their physiological roles (7). Figure 1 summarizes the current overview of the 
brain RAS. 
 
 
 
 
Figure 1. Intraneuronal and extraneuronal synthesis of angiotensin fragments in the brain. ACE: 
angiotensin converting enzyme; AP-A: aminopeptidase A; PO: propyloligopeptidase. AT1, AT2, 
AT4, Mas: angiotensin postsynaptic receptors. Adapted from Paul M. et al., Physiol Rev 86:747, 
2006. 
 
 
PHYSIOLOGICAL ACTIONS OF ANGIOTENSIN II IN THE CNS 
 
Two mechanisms have been proposed to explain central actions of ANG II. Brain 
ANG II receptors located in neurons inside the BBB can be stimulated either by ANG II 
generated in the brain or circulating ANG of peripheral origin as well, and transported into 
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the brain. On the other hand, some ANG II receptors are located outside de BBB in 
vascular endothelial cells or CVOs like the SFO, OVLT, median eminence, area postrema 
(AP) and the anterior pituitary lobe. The CVOs are sensitive and respond to brain ANG II 
being also a target site for circulating ANG II (6).  
One of the main characteristics of ANG system is that it may regulate several 
physiological actions through either direct or indirect pathways. ANG may exert direct 
actions on the CNS through stimulation of target organs or tissues, while it induces indirect 
actions by stimulating synthesis and/or secretions of regulatory hormones or 
neurotransmitters which in turn, are responsible for modulation of central/peripheral effects 
on target organs or tissues activities. 
Two types of receptors mediate the physiological action of ANG II in the CNS, the 
AT1 and AT2 receptors. Table 1 shows the distribution of these receptors in the CNS. 
 
 
Table 1. Distribution of Angiotensin receptors in the Central Nervous System. Adapted from 
Function of Neuropeptides at Central Nervous System, Chapter 3, Ed. Research Signpost, 2009.  
 
 
Physiological effects mediated by AT1 and AT2 receptors 
 
Brain AT1 receptors induce stimulation of: 
- drinking behaviour 
- salt intake  
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- alcohol intake, via dopaminergic interaction 
- stress brain response, including stress–induced gastric injury 
- vasoconstriction of cerebral arterioles 
- neuronal norepinephrine release and turnover and norepinephrine-mediated 
neuromodulation 
- L and T type calcium channels  
- visual and somatosensory areas in thalamus 
- anxiety  
- inflammation 
 
Brain AT1 receptors induce inhibition of: 
- K+ channels 
- GABA and glutamatergic transmission 
- long term potentiation of synaptic plasticity 
- neuronal NE uptake 
- NMDA (N-methyl-D-aspartate)-induced neuronal stimulation 
 
The function of AT2 receptors remains controversial. AT2 receptors counterbalance 
some of the biological effects of AT1 receptor signalling on vascular resistance and 
antinatriuretic effects.  
AT2 receptors may also decrease the sensitivity to pain, while they exacerbate 
several other neuronal activities such as:  
- ionic currents 
- cell differentiation 
- axonal regeneration after nerve crush 
- modulation of programmed cell death (growth inhibition and promotion of 
apoptosis) 
- transient K+ current. Reduces the length of action potentials and the refractory 
period leading to an increase in membrane excitability 
- acquisition of conditional avoidance responses 
- growth arrest 
- cell migration 
- cerebral circulation and cerebrovascular development 
- blood flow to basal forebrain and pituitary gland 
- β endorphin secretion 
- body temperature 
 
Figure 2 summarizes the main actions of ANG II at the CNS.  
 
Body fluid homeostasis, sodium and water balance, dipsogenic action and arginine-
vasopressin secretion 
ANG II regulates body fluids, stimulating thirst and salt appetite (via AVP and 
CRH-ACTH-glucocorticoids secretion) in the hypothalamus, and inhibiting natriuresis and 
diuresis (via AVP secretion). The MePON, SFO and OVLT contain AT1 and volume-
receptors and osmoreceptors for control, regulation and homeostasis of body fluids (8).                        
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Figure 2. Main actions of Angiotensin II on Central Nervous System. NE: norepinephrine; NMDA: 
N-methyl-D-aspartate.  
 
 
Regulation of sympathetic tone and activity and control of cardiovascular function 
and blood pressure 
Brain ANG II modulates the sympathetic tone in the hypothalamus, brainstem and 
medulla. Indirect effects are exerted on the anterior hypothalamus where ANG II regulates 
NE transmission and sympathetic activity and stimulates AVP and CRH secretion (9,10). 
Brain ANG regulates the cardiovascular function and blood pressure. ANG II increases 
blood pressure through sympathetic activation, AVP, CRH and ACTH secretion and 
decreases sympathetic baroceptor sensitivity by means of AT1 receptors activation in the 
NTS (11). Moreover, enhanced central sympathetic activity results in an increase in 
vasoconstrictor activity (12). In this way ANG II induces tonic sympathoexcitatory effects 
through AT1 receptor stimulation of glutamatergic neurons and sympathoinhibitory effects 
via GABAergic neurons in the rostral ventrolateral medulla, the brainstem 'pressor area' 
(13). 
 Brain generated ANG II acts as neuromodulator or a neurotransmitter in order to 
process and sense the afferent information received from baroceptors in diverse nuclei 
associated with cardiovascular control (6,9,12). ANG II modulates neuronal activity 
through AT1 or AT2 receptors, changing the activity of membrane ionic currents and 
channels in areas implied in blood pressure regulation, like the locus coeruleus, the 
hypothalamic PVN and the NTS where ANG II receptors receive afferent terminals from 
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the dorsal motor nucleus of the vagus, the rostral and caudal ventrolateral medulla and the 
intermediolateral cell column of the spinal cord (14,15). 
 
Catecholaminergic, serotonergic, GABAergic and glutamatergic neurotransmission 
Brain RAS and catecholamines (NE, epinephrine, dopamine) are co-localized in 
several areas of the CNS, including several nuclei of the forebrain (mainly hypothalamic 
nuclei) and the brainstem (i.e., the NTS). Both ANG II and ANG III stimulate central 
sympathetic activity regulating NE neurotransmission at the presynaptic nerve ending level. 
There is an inverse relationship between ANG II circulating levels and NE content in the 
CNS. ANG II increases spontaneous release and potassium or acetylcholine NE-evoked 
release, and decreases NE neuronal uptake in hypothalamus and medulla oblongata (10). 
These effects are not tissue-specific as they were shown in different areas of the CNS.  
ANG II increases NE content in subcellular granular stores and decreases it in 
cytoplasmatic neuronal compartments, diminishes NE turnover and enhances NE neuronal 
synthesis, transporter (NET), tyrosine-hydroxylase expression and dopamine β-hydroxylase 
mRNA transcription. All these actions result in an enhanced NE availability at the synaptic 
gap, with the consequent increase in sympathetic activity. ANG II also stimulates MAO 
activity in hypothalamus (10,16). AT1 receptors mediate ANG II effects on NE 
neurotransmission, while AT2 receptors are not involved (17). ANG II effects on NE uptake 
in the CNS are reversed by low and non-effective doses of ANP (10).  
AT1 receptors located pre-and postsynaptically may influence norepinephrinergic, 
GABAergic, and/or glutamatergic transmission (18-20). ANG II stimulates spinally 
projecting neurons in the PVN by attenuation of GABAergic synaptic inputs (21) and 
inhibits NMDA receptor (N-methyl-D-aspartate)-induced neuronal stimulation in the 
amygdale (22). ANG II increases GABA (B) receptor expression and augments GABA (B) 
receptor-mediated responses in the NTS, contributing to central ANG actions that result in 
dampening of baroreflexes and elevation of arterial blood pressure (23). Figure 3 shows 
ANG II effects on central neurotransmission. 
 
Atrial natriuretic peptide 
ANP, BNP and CNP are synthesized and released in the CNS. There is a strong 
correlation between ANP and ANG II and their respective receptors localization in the 
CNS. These natriuretic peptides are the physiological antagonists of brain RAS and exhibit 
opposite effects to ANG II on neuronal NE uptake, release, endogenous content and 
turnover in the hypothalamus. ANP also opposes to ANG II-induced increase in MAO 
activity and inhibits ANG II-induced water intake in the brain as well as ANG II stimulated 
secretion of CRH, AVP and OT (10).   
 
Development and neuronal growth, differentiation, proliferation, regeneration and 
apoptosis 
ANG II acts through AT1 receptors as a growth factor and promotes protein 
synthesis and fibroblast proliferation (24). During the embryonic life, AT2 receptors are 
mainly located in areas closely related with the development, and their number, decreases 
after birth (24). In adults, AT2 receptors are found in areas related to sensory and motor 
control and integration, visual pathways, limbic system activity and behavior. AT2 
receptors promote axonal regeneration after nerve crush (25), growth arrest and cell 
migration. Moreover, AT2 activation modulates programmed cell death by the inhibition of 
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growth and apoptosis promotion through activation of MAP kinases (10), promotes nerve 
generation and neuronal differentiation in cells of neuronal origin, through an increase in 
NO production and mediates anti-proliferative effects in different cells lines (10).  
 
 
 
 
Figure 3. Effects of Angiotensin II on diverse neurotransmission systems (mainly mediated by AT1 
receptors). NE: norepinephrine.  
 
 
Neuronal ion channels and excitability 
ANG II regulates ionic currents in neuronal tissues. AT1 and AT2 stimulation cause 
opposite effects on calcium and potassium channels. AT1 stimulation enhances calcium 
release from intracellular stores and its influx from the extracellular space, increasing 
intracellular calcium in astroglial cells. In hypothalamus and brain stem areas, ANG II 
increases the neuronal firing rate, which involves the inhibition of the delayed rectifier 
potassium current. On the other hand, ANG II stimulates both, transient K+ current and 
delayed-rectifier K+ current via AT2 receptors in brain stem neurons (10). AT2-induced 
activation of transient potassium currents is associated with a reduction in the length of 
action potentials and a shortening of the refractory period, which lead to an increase in 
membrane excitability (26). AT2 activation also lowers body temperature. This effect could 
be related to the increase in membrane excitability of neurons associated to body 
temperature control, as well as to vasodilation of cerebral vessels in hypothalamic areas. 
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Moreover, activation of AT2 increases the firing rate in thalamus and amygdala, suggesting 
that GABA A receptors are involved in ANG-II-induced effects on neuronal activity (10).  
 
Cognition, memory, behavior and emotion. Motor and somatosensory control 
Brain ANG II influences cognitive functions, emotional processes and behavioral 
changes by acting on specific AT1 receptors. Treatment with ANG II receptor blockers 
prevents amyloid beta deposition in the brain and attenuate cognitive impairment in elderly 
individuals and in Alzheimer disease (27).  
In the hippocampus, stimulation of AT1 and/or AT2 receptors blocks memory 
formation, retention and consolidation (28,29). Conversely, ANG II facilitates learning and 
consolidation of retention and memory, probably through ANG IV formation which 
interacts with GABA neurotransmission (10). Thus, different responses might be obtained 
depending on the time intervals between ANG II injection and the behavioral paradigm 
tested.  
Brain administration of ANG II blocks long-term potentiation induction of synaptic 
plasticity in the amygdala, a specific process of behavioral significance related to learning 
and memory (10,29). This inhibition is related to presynaptic ANG II action on 
glutamatergic terminals and with postsynaptic inhibition of NMDA receptors (30,31). The 
inhibition of AT2 abolishes the ANG-II-induced acquisition of conditioned avoidance 
responses (32). The AT2-mediated increase of neuronal firing rate seems to involve 
lipoxygenase metabolites of arachidonic acid generation and serine/threonine phosphatase 
type 2A activation. ANG II up-regulates AT2 mRNA levels in rat cortical neurons, through 
regulation of serine/threonine phosphatases activity (10). Taken together, these findings 
support the hypothesis that, in addition to their role during development, AT2 receptors may 
also be involved in cognitive processes in the adult and modulate behavioral effects, mood 
and pain threshold, and indicate a critical role of ANG II in cognitive impairment 
associated with vascular disease, Alzheimer disease, metabolic syndrome and other 
neurodegenerative diseases (27). 
In addition, ANG II increases firing rates in the visual and somatosensory thalamus, 
in the hippocampus and in the superior colliculus and induced neuronal excitation in the 
inferior olivary nucleus suggesting that it has a role in information processing and in 
control of locomotor activity. Brain RAS is also involved in sensitivity control. Stimulation 
of AT2 decreases the sensitivity to pain and augments β endorphin secretion (10,25).  
 
Anxiety-Alcohol consumption 
AT1 stimulation increases anxiety. This effect is mediated by ANG II interaction 
with benzodiazepine receptors and by increasing prazosin-binding sites in the amygdala. 
Conversely, AT2 receptors stimulation decreases anxiety (33). AT1 also stimulate alcohol 
consumption in the CNS, reducing dopamine concentration in the ventral tegmental area, 
supporting a role for dopaminergic transmission in ANG-II-induced alcohol preference 
(34).  
 
Cerebrovascular flow. Stroke. Protection against ischemia 
ANG II regulates cerebral blood flow, exerting vasoconstriction which favors 
ischemia and cerebral stroke. AT1 over-stimulation exacerbates cerebrovascular 
pathological growth and remodelling with inflammatory reaction in cerebral blood vessels 
and decreased compliance, impaired cerebral autoregulation, increased cerebrovascular 
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eNOS/iNOS ratio and NO formation. Centrally AT1 blockers normalize cerebrovascular 
flow, decreasing macrophage infiltration and TNF-α,  interleukin-1β and NFk-β expression 
in microvessels in hypertensive rats. AT1 blockade in SHR rats decreases brain 
vulnerability to ischemia and neuronal death during experimental stroke and reduces the 
size of the infarct after occlusion of cerebral arteries. Then, treatment with AT1 antagonists 
may be useful for prevention of ischemia and inflammatory diseases of the brain (35,36).  
AT2 receptors also contribute to the autoregulation of cerebrovascular resistance and 
blood flow. The decreased number of AT2 in aged rats can be involved in the 
pathophysiology of cerebrovascular dysfunction. AT2 stimulation induces cerebrovascular 
angiogenesis and vasodilation and augments circulation and blood flow to the forebrain and 
pituitary gland by mean of NO and prostacyclins release during hemorrhagic hypotension 
in rats. ANG II also alters BBB permeability through prostaglandins release, allowing the 
transport of substances across the cerebral capillary endothelium (35.37). Therefore, ANG 
II exerts stroke-protective effects through stimulation AT2 receptors. ANG II receptor 
blockers exert a dual influence, since AT1 blockade decreases local vasoconstriction, 
allowing free ANG II to stimulate the unoccupied AT2 receptor and increase local 
vasodilation, diminishing local brain ischemia and the volume and extent of brain damage 
(38,39). 
 
Control of hormone secretion. Hypothalamus, hypophysis and adrenal glands 
Brain ANG II controls reproductive function and the hypothalamic-pituitary-adrenal 
axis and increases NE release in the hypothalamus. Considering that NE stimulates 
hypothalamic releasing factors, brain ANG II may control the anterior pituitary lobe 
secretion by means of NE-dependent indirect regulation of hypothalamic releasing factors 
formation and release from de median eminence to the pituitary portal circulation, in order 
to exert their effects on the hypophysis. Moreover, the complete RAS is present in the 
anterior pituitary lobe, where ANG II is detected in gonadotrophic (co-localized with LH), 
lactotrophic, corticotrophic and probably thyrotrophic cells (6).   
 
CRH-ACTH –Glucocorticoids cascade and stress 
ANG II is involved in the regulation of adrenocortical hormones, by modulating the 
synthesis and release of CRH, ACTH and glucocorticoid levels (10). ANG II regulates 
ACTH secretion, either directly at the pituitary gland or indirectly by increasing CRH or 
AVP synthesis and release from the hypothalamic PVN (29). ACTH release is also 
increased by stimulation of ANG II receptors placed outside the BBB in the SFO. ANG II 
effects on CRH synthesis takes place in the parvocellular PVN and CRH release is 
produced in the median eminence (10).  
Brain ANG II and AT1 receptors increase during stress and produce anxiety. Brain 
AT1 blockade reduces anxiety and prevents ANG II-induced hormonal and 
sympathoadrenal response to stress, like the increase in CRH release and the consequent 
augment of ACTH and glucocorticoids secretion and also prevents the ulcerations of the 
gastric mucosa produced by stress, by preserving gastric blood flow and avoiding 
inflammation (40).  
 
Mineralocorticoids 
A feedback mechanism between brain RAS, sodium levels and mineralocorticoids 
was described. ANG II controls salt appetite and sodium excretion and conversely, plasma 
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sodium and mineralocorticoids up-regulate central ANG II receptors. Aldosterone and 
deoxycorticosterone cross the BBB enhancing ANG II induction on sodium appetite and 
dipsogenic action, as a result of an increase in brain AT1 receptor number at the PVN, 
MePON, SFO, NTS and AP (6). 
 
Prolactin, Gonadotrophins, LH secretion  
Brain ANG II controls the reproductive function since it stimulates oxytocin, LH-
RH, LH and reduces prolactin release.  Central ANG II inhibits pituitary prolactin release 
indirectly via modulation of dopaminergic activity in the arcuate nucleus. This process 
depends on estrogen and progesterone levels. Moreover, ANG II can be an intermediate of 
LHRH on pituitary LH secretion. Since ANG II and LHRH are co-localized in OVLT 
neurons, ANG II may release NE, enhancing LHRH secretion and thus, indirectly, 
stimulating LH secretion. AT1B receptors located in pituitary lactotrophic and 
corticotrophic cells stimulate PLC activity and IP3 and diacylglycerol (DAG) formation, 
suggesting a direct paracrine action of ANG II on the anterior hypophyseal lobe. During 
pregnancy, elevated plasma levels of ANG II may contribute to increase sympathetic nerve 
activity and attenuate baroreflex gain markedly in this condition (9,10). 
 
Sexual hormones. Estrogens, progesterone and androgens 
Pituitary anterior lobe RAS is under the control of sexual hormones. The number of 
AT1 receptors changes during the oestrous cycle, being high during metaestrus, decreases 
during oestrus and diestrus, attaining the lower during proestrus. In addition, AT1 receptors 
are very low in male and ovariectomized female rats. 17β-estradiol and progesterone 
treatment increases AT1A-mRNA expression in tyrosine hydroxylase synthesizing neurons 
of the dorsal arcuate nucleus, but decreases the expression in the MePON and anterior 
pituitary. This explains why estrogens diminish some central ANG II effects. On the other 
hand, androgens increase renin activity and ANG II synthesis in the anterior pituitary lobe 
(10).  
 
Growth hormone 
Pituitary ANG II decreases growth hormone (GH) secretion by a direct action on 
somatotrophic cells of the hypophysis (36).  
 
Vasopressin and oxytocin 
Brain ANG II stimulates AVP and OT synthesis (in the hypothalamus) and 
secretion (in the posterior pituitary lobe). These effects can be exerted at different levels: a) 
as a paracrine effect in the hypothalamic nuclei PVN and SON; b) from the median 
eminence to the portal blood vessels and c) in the posterior pituitary lobe, from the neural 
terminals of the hypothalamic-hypophyseal tract. AVP synthesis and secretion are exerted 
mainly in magnocellular neurons of the PVN, where most of AT1 receptors are located. 
Moreover, the presence of angiotensinogen, renin, ACE, ANG II and its receptors have 
been described in the posterior lobe but the functionality of the RAS system in these areas 
has not been clarified (6).  
 
Vision system 
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In the superior colliculus, ANG II-AT1 activation markedly reduces the amplitude 
of visual evoked potentials, and AT2 binding decreased after bilateral eye enucleation, 
suggesting that ANG II receptors may be regulated by retinal inputs (10,25). 
 
Hypertension 
Higher expression and exacerbated activity of the brain RAS components may play 
a role in the pathogenesis and development of hypertension in several experimental models 
of hypertension, as in genetically spontaneously hypertensive rats (SHR), DOCA-salt, 
Goldblatt 2K-1C, sino-aortic denervated and pregnancy-induced hypertension. 
Hypertensive states exhibit an enhanced response to ANG II, a decreased catabolism of the 
peptide and increased ANG II receptors in selected brain and brainstem areas, as it was 
shown in SHR rats (2,35,36,41). The sino-aortic denervated rat shows enhanced ANG II 
binding sites in the anterior pituitary. In addition, ANG II receptors are increased in brain 
nuclei and areas (MePON, SFO, PVN, NTS and AP) of DOCA-salt hypertensive rats. AT1 
stimulation attenuates the hypotensive action of central α2 receptors and stimulates β 
adrenoceptors, increasing collagen synthesis and deposition on brain microvessels. 
Consequently, ANG microinjection in the NTS causes hypertension and inhibition of the 
baroreflex. Τhe enhanced pressor response to ANG II injection observed in the 
hypothalamus of fructose-induced hypertensive rats is mediated by stimulation of β1 
adrenoceptors and attributed to increased AT1 and β1 receptors tone (10,42).         
  
Inflammation 
 Stimulation of AT1 receptors, colocalized with NAD(P)H oxidase in NTS neurons, 
induces local reactive oxygen species production and the development of inflammation 
(41). The RAS plays a pivotal role in autoimmune inflammation of the CNS, being its 
blockade a potential new target for multiple sclerosis therapy. In this way, the renin 
inhibitor aliskiren, the ECA inhibitor enalapril, or the preventive/therapeutic administration 
of AT1 antagonist losartan, strongly ameliorated the course of multiple sclerosis (43).  
 
 
 
REFERENCES 
 
1. Bickerton R and Buckley J. Evidence for a central mechanism in angiotensin induced 
hypertension. Proc Soc Exp Biol Med 106: 834-836, 1961. 
2.  Saavedra JM. Brain and pituitary angiotensin. Endocr Rev 13: 329-380, 1992.  
3. Ferguson AV, Washburn DL, and Latchford KJ. Hormonal and neurotransmitter roles for 
angiotensin in the regulation of central autonomic function. Exp Biol Med 226: 85-96, 2001. 
4. Re RN. On the biological actions of intracellular angiotensin. Hypertension 35: 1189-1190, 2000. 
5. Von Bohlen und Halbach O and Albrecht D. The CNS renin-angiotensin system. Cell 
Tissue Res 326: 599-616, 2006. 
6. Antunes-Rodrigues J, de Castro M, Elias LLK, Valenca MM, and McCann SM. 
Neuroendocrine control of body fluid metabolism. Physiol Rev 84: 169-208, 2004. 
7.  Haulica I, Bild W, and Serban D. Angiotensin peptides and their pleiotropic actions. JRAAS 6: 
121-131, 2005. 
 Physiological Mini Reviews Vol. 5, Nº5, 18-31; 2011                   29
 
 
 
8.  Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 78: 583-686, 1998. 
9.  Brooks VL, Dampney RA, and Heesch CM. Pregnancy and the endocrine regulation of 
the baroreceptor reflex. Am J Physiol Regul Integr Comp Physiol 299: 439-451, 2010. 
10. G.R de Lores Arnaiz. Function of Neuropeptides at Central Nervous System. Chapter 3: 53-99, 
Research Signpost, 2009. 
11. Matsumura K, Averill DB, and Ferrario CM. Angiotensin II acts at AT1 receptors in the nucleus 
of the solitary tract to attenuate the baroreceptor reflex. Am J Physiol Regul Integr Comp Physiol 
275: 1611-1619, 1998. 
12. Fernández BE, Domínguez AE, Vidal NA, and Martínez Seeber A. Modifications of 
arterial pressure and plasma renin: their effects on the norepinephrine content of 
hypothalamus and medulla oblongata. Arch Int Physiol Biochim 85: 287-293, 1977.  
13. Dupont AG and Brouwers S. Brain angiotensin peptides regulate sympathetic tone and 
blood pressure. J Hypertens 28: 1599-1610, 2010. 
14. Pan HL. Brain angiotensin II and synaptic transmission. Neuroscientist 10: 422-431, 
2004.  
15. Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, and Mendelsohn FA. 
Angiotensin receptors in the nervous system. Brain Res Bull 47: 17-28, 1998. 
16. Fernández BE and Domínguez AE. Angiotensin II increases MAO activity in rat central 
nervous system. Rev Esp Fisiol 47: 37-40, 1991. 
17. Rodríguez Campos M, Kadarian C, Rodano V, Bianciotti L, Fernández B, and Vatta M. 
AT-1 receptor and phospholipase C are involved in angiotensin III modulation of 
hypothalamic noradrenergic transmission. Cell Mol Neurobiol 20: 747-762, 2000.  
18. Barnes KL, DeWeese DM, and Andresen MC. Angiotensin potentiates excitatory 
sensory synaptic transmission to medial solitary tract nucleus neurons.  Am J Physiol Regul 
Integr Comp Physiol 284: 1340-1353, 2003.  
19. Ozaki Y, Soya A, Nakamura J, Matsumoto T, and Ueta Y. Potentiation by angiotensin 
II of spontaneous excitatory postsynaptic currents in rat supraoptic magnocellular neurones.  
J Neuroendocrinol 16: 871-879, 2004. 
20. Oz M, Yang KH, O´Donovan MJ, and Renaud LP. Presynaptic angiotensin II AT1 receptors 
enhance inhibitory and excitatory synaptic neurotransmission to motoneurons and other ventral 
horn neurons in neonatal rat spinal cord. J Neurophysiol 94: 1405-1412, 2005. 
21. Li DP, Chen SR, and Pan HL. Angiotensin II stimulates spinally projecting 
paraventricular neurons through presynaptic disinhibition. J Neurosci 23: 5041-5049, 2003. 
22. Tchekalarova J and Albrecht D. Angiotensin II suppresses long-term depression in the 
lateral amygdala of mice via L-type calcium channels. Neurosci Lett 415: 68-72, 2007.  
23. Zhang Q, Yao F, O'Rourke ST, Qian SY, and Sun C. Angiotensin II enhances GABA(B) 
receptor-mediated responses and expression in nucleus tractus solitarii of rats. Am J Physiol Heart 
Circ Physiol 297: 1837-1844, 2009. 
24. Dinh DT, Frauman AG, Johnston CI, and Fabiani ME. Angiotensin receptors: 
distribution, signalling and function. Clin Sci 100: 481-492, 2001.  
25. Paul M, Poyan Mehr A, and Kreutz R. Physiology of local renin-angiotensin systems. 
Physiol Rev 86: 747-803, 2006. 
26. Gendron L, Payet MD, and Gallo-Payet N. The angiotensin type 2 receptor of 
angiotensin II and neuronal differentiation: from observations to mechanisms. J Mol 
Endocrinol 31: 359-372, 2003. 27. Mogi M and Horiuchi M. Effects of angiotensin II 
receptor blockers on dementia. Hypertens Res 32: 738-740, 2009.  
 Physiological Mini Reviews Vol. 5, Nº5, 18-31; 2011                   30
 
 
 
28. Kerr DS, Bevilaqua LR, Bonini JS, Rossato JI, Kohler CA, Medina JH, Izquierdo I, and 
Cammarota M. Angiotensin II blocks memory consolidation through an AT2 receptor-
dependent mechanism. Psychopharmacology 179: 529-535, 2005.  
29. Phillips MI and de Oliveira EM. Brain renin angiotensin in disease. J Mol Med 86: 715-722, 
2008. 
30. Albrecht D, Hellner K, Walther T, and von Bohlen und Halbach O. Angiotensin II and the 
amygdala. Ann N Y Acad Sci 985: 498-500, 2003. 
31. Drephal C, Schubert M, and Albrecht D. Input-specific long-term potentiation in the rat lateral 
amygdala of horizontal slices. Neurobiol Learn Mem 85: 272-282, 2006. 
32. Braszko JJ. AT(2) but not AT(1) receptor antagonism abolishes angiotensin II increase of the 
acquisition of conditioned avoidance responses in rats. Behav Brain Res 131: 79-86, 2002. 
33. Braszko JJ, Kulakowska A, and Winnicka MM. Effects of angiotensin II and its 
receptor   antagonists on motor activity and anxiety in rats. J Physiol Pharmacol 54: 271-
281, 2003.  
34. Maul B, Krause W, Pankow K, Becker M, Gembardt F, Alenina N, Walther T, Bader 
M, and Siems WE. Central angiotensin II controls alcohol consumption via its AT1 
receptor. FASEB J 19: 1474-1481, 2005. 
35. Saavedra JM, Benicky J, and Zhou J. Mechanisms of the Anti-Ischemic Effect of Angiotensin II 
AT( 1 ) Receptor Antagonists in the Brain. Cell Mol Neurobiol 26: 1099-1111, 2006. 
36. Saavedra JM, Benicky J, and Zhou J. Angiotensin II: multitasking in the brain. J Hypertens 24: 
131-137, 2006. 
37. Saavedra JM. Brain angiotensin II: new developments, unanswered questions and therapeutic 
opportunities. Cell Mol Neurobiol 25: 485-512, 2005. 
38. Chrysant SG. The pathophysiologic role of the brain renin-angiotensin system in stroke 
protection: clinical implications. J Clin Hypertens 9: 454-459, 2007. 
39. Schrader J, Kulschewski A, and Dendorfer A. Inhibition of the renin-angiotensin system and the 
prevention of stroke. Am J Cardiovasc Drugs 7: 25-37, 2007. 
40. Saavedra JM and Benicky J. Brain and peripheral angiotensin II play a major role in 
stress. Stress 10: 185-193, 2007. 
41. Cheng WH, Lu PJ, Ho WY, Tung CS, Cheng PW, Hsiao M, and Tseng CJ. Angiotensin 
II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling 
pathway to modulate central control of blood pressure. Circ Res 106: 788-795, 2010. 
42. Mayer MA, Höcht Ch, Gironacci M, Opezzo JAW, Taira CA, Fernández  BE, and Puyó 
AM. Hypothalamic angiotensinergic-noradrenergic systems interaction in fructose induced 
hypertension. Regul Pept 146: 38-45, 2008. 
43. Stegbauer J, Lee DH, Seubert S, Ellrichmann G, Manzel A, Kvakan H, Muller DN, 
Gaupp S, Rump LC, Gold R, and Linker RA. Role of the renin-angiotensin system in 
autoimmune inflammation of the central nervous system. Proc Natl Acad Sci USA 106: 
14942-14947, 2009.  
 
 
 Physiological Mini Reviews Vol. 5, Nº5, 18-31; 2011                   31
